At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Short Term Clinical Study Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity
In Brief
A Phase 4 clinical trial evaluating Stannous Fluoride Dentifrice and Sodium monofluorophosphate Dentifrice for Dentin Sensitivity. Completed, enrolled 143 participants across 1 site.
Detailed Summary
This will be a single centre, two week, randomised, examiner blind, two treatment arm, parallel design, stratified (by maximum baseline Schiff sensitivity score of the two selected test teeth), controlled study, in participant with at least two sensitive teeth that meet the study criteria at the Screening and Baseline visits. The study will be conducted in participants in good general health, with pre-existing self-reported and clinically diagnosed tooth sensitivity at screening.
Study Details
Timeline
Interventions
Experimental dentifrice containing 0.454%w/w stannous fluoride (1100ppm fluoride)
Dentifrice containing 0.76% w/w sodium monofluorophosphate (1000ppm fluoride)